- Home
- SION
as 03-13-2025 4:00pm EST
Stocks
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which Heads to insufficient CFTR function.
| Founded: | 2019 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 583.9M | IPO Year: | 2025 |
| Target Price: | $32.00 | AVG Volume (30 days): | 202.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -16.77 | EPS Growth: | N/A |
| 52 Week Low/High: | $13.21 - $25.19 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest SIONNA THERAPEUTICS INC News
SION Breaking Stock News: Dive into SION Ticker-Specific Updates for Smart Investing
Insider Monkey
7 days ago
Is Sionna Therapeutics, Inc. (SION) Among Stocks With At Least $20 Million In Insider Spending Recently?
Insider Monkey
10 days ago
Sionna Therapeutics, Inc. (SION): Among Stocks With At Least $10 Million In Insider Spending Recently
Pharmaceutical Technology
16 days ago
Sionna Therapeutics’ IPO: A strategic shift in the cystic fibrosis market
GlobeNewswire
17 days ago
Sionna Therapeutics to Present at the 45th Annual TD Cowen Health Care Conference
Insider Monkey
24 days ago
Is Sionna Therapeutics (SION) Among Stocks Insiders Are Buying This Year?
GlobeNewswire
a month ago
Sionna Therapeutics Announces Closing of $219.2 million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Compare SION vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SION SIONNA THERAPEUTICS INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.